Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Jun Zeng 1 Article
Gastrointestinal cancer
A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote Colorectal Cancer Tumorigenesis
Jun Zeng, Xiao-qing Xiao, Zhi-yong Zhou
Cancer Res Treat. 2022;54(2):525-540.   Published online June 29, 2021
DOI: https://doi.org/10.4143/crt.2021.373
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Emerging evidence has shown that SKP1-cullin-1-F-box-protein (SCF) E3 ligases contribute to the pathogenesis of different cancers by mediating the ubiquitination and degradation of tumor suppressors. However, the functions of SCF E3 ligases in the pathogenesis of colorectal cancer (CRC) remain obscure.
Materials and Methods
The cancerous and adjacent noncancerous tissues from CRC patients were collected, and protein levels were analyzed. Lentiviral short hairpin RNA (shRNA) and plasmid transfection were used to knock down and overexpress gene expression in CRC cell lines. Immunoprecipitation (IP), mass spectrometry, and co-IP analyses were used to determine protein interactions and the assembly of the SCF complex. Cell proliferation, migration, and tumor xenograft assays were performed to examine the effects of SCF members on CRC cell growth in vitro and in vivo.
Results
Hypoxia activated the docking of hypoxia-inducible factor 1α (HIF1α) onto the CUL1 promoter and induced CUL1 expression in CRC cells. CUL1 coupled with RBX1, SKP1, and FBXL1 to assemble the SCFFBXL1 complex in CRC biopsies and cells. The SCFFBXL1 E3 ligase specifically ubiquitinated and degraded the MEN1 tumor suppressor. Knockdown of HIF1α or SCFFBXL1 members, or blockage of SCFFBXL1 by two inhibitors (DT204 and SZLP1-41) caused the accumulation of MEN1 protein and led to a significant decrease in cell proliferation and migration in vitro and tumor growth in vivo.
Conclusion
The SCFFBXL1 E3 ligase is required for the ubiquitination of MEN1, and disruption of this complex may represent a new therapeutic strategy for the treatment of CRC.

Citations

Citations to this article as recorded by  
  • Role of protein degradation systems in colorectal cancer
    Zihan Cui, Mingqi Cong, Shengjie Yin, Yuqi Li, Yuguang Ye, Xi Liu, Jing Tang
    Cell Death Discovery.2024;[Epub]     CrossRef
  • Spatially resolved transcriptomics revealed local invasion-related genes in colorectal cancer
    Hong-Tao Liu, Si-Yuan Chen, Ling-Long Peng, Li Zhong, Li Zhou, Si-Qi Liao, Zhi-Ji Chen, Qing-Liang Wang, Song He, Zhi-Hang Zhou
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells
    Jun Wang, Zhiyong Zhou
    Discover Oncology.2023;[Epub]     CrossRef
  • Rational targeting of autophagy in colorectal cancer therapy: From molecular interactions to pharmacological compounds
    Canhui Jin, Tianbao Wang, Yanhui Yang, Pin Zhou, Juncheng Li, Wenhao Wu, Xin Lv, Guoqing Ma, Aihong Wang
    Environmental Research.2023; 227: 115721.     CrossRef
  • 6,457 View
  • 141 Download
  • 4 Web of Science
  • 4 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP